Pharos Capital Group

Profile

Pharos Capital Group is a private equity firm based in the United States, co-founded by Dr. Kneeland Youngblood, a former emergency room physician, and Bob Crants in 1998. The firm is headquartered in Dallas, Texas, and focuses exclusively on the healthcare sector, particularly on companies that address disparities in access to care within underserved communities across the U.S. Pharos Capital is notable for its commitment to investing in businesses that enhance healthcare accessibility and quality in rural, urban, and tribal areas, aligning their financial goals with social impact.

The firm invests in healthcare companies with a focus on sectors such as chronic disease management, telepsychiatry, behavioral health, medication management, prevention, and early detection. They emphasize a holistic approach that includes addressing social determinants of health. With over $1.5 billion raised in capital since inception, Pharos operates with a 100% healthcare-focused strategy. They serve throughout the United States with investments in over 1,600 locations, bringing healthcare solutions directly to communities in need. Pharos' portfolio includes Fund III which is specifically focused on improving healthcare in underserved communities.

Notable portfolio companies include FasPsych, which provides scalable telepsychiatry solutions; Sanderling Renal Services, offering at-home dialysis and remote kidney care; and Beacon Specialized Living, supporting people experiencing homelessness or severe mental illness. Pharos Capital is designated as a Minority Business Enterprise, and a significant portion of its workforce stems from the communities its portfolio serves, emphasizing local hiring and economic impact.